Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
Fudan University
Fudan University
Memorial Sloan Kettering Cancer Center
Stanford University
Stanford University
City of Hope Medical Center
Stanford University
Trans Tasman Radiation Oncology Group
National Cancer Institute (NCI)